Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-2652

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008

Creator: Nhung, VT Tuyet

Contributor: Colby, D.
Thuy, H Thu
Thuy, L Vinh
Vinh, DT Nhat
Giang, L Truong
SpringerLink (Online service)

DOI: 10.1186/1758-2652-11-S1-P77

URN: urn:nbn:de:1111-2016052055318

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Nhung, VT Tuyet
Colby, D.
Thuy, H Thu
Thuy, L Vinh
Vinh, DT Nhat
Giang, L Truong
SpringerLink (Online service)

Other Objects (12)

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Gliederung

Verfahren ARV

Kinderbuch | Kinderbücher bis 11 Jahre

Vandrarnas arv

Fotografie

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Gliederung

Verfahren ARV

Kinderbuch | Kinderbücher bis 11 Jahre

Vandrarnas arv

Fotografie

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Gliederung

Verfahren ARV

Kinderbuch | Kinderbücher bis 11 Jahre

Vandrarnas arv

Fotografie

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Verfahren ARV

Vandrarnas arv

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Verfahren ARV

Vandrarnas arv

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Virological and immunological response to three boosted protease inhibitor regimens

Long-term virological outcome in children receiving first-line antiretroviral therapy

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Verfahren ARV

Vandrarnas arv

Rübenvorratsroder ARV

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens

Related objects

Reset password